|
Sign In to gain access to subscriptions and/or personal tools.
|
Identifying Unrecognized Peripheral Arterial Disease Among Asymptomatic Patients in the Primary Care Setting
Chyke A. Doubeni, MBBS, MPH
Department of Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, Meyers Primary Care Institute, the University of Massachusetts Medical School and Fallon Foundation, Worcester, Chyke.Doubeni{at}umassmed.edu
Robert A. Yood, MD
Meyers Primary Care Institute, the University of Massachusetts Medical School and Fallon Foundation, Worcester, Fallon Clinic, Inc, Worcester, MA
Srinivas Emani, PhD
Fallon Clinic, Inc, Worcester, MA
Jerry H. Gurwitz, MD
Department of Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, Meyers Primary Care Institute, the University of Massachusetts Medical School and Fallon Foundation, Worcester
National initiatives to enhance recognition of the detrimental impact of peripheral arterial disease on the health of adult Americans have been advocated. The objective of this study was to evaluate a strategy for identifying patients with unrecognized peripheral arterial disease from among persons without known atherosclerotic disease in the primary care setting. A cross-sectional design was used. Participants were patients receiving care from a multispecialty group practice in Massachusetts between July 2002 and July 2003, with a scheduled appointment with a primary care physician. Persons 70 years of age or older who were not already known to have atherosclerotic disease were enrolled. In addition, persons aged 50-69 with a diagnosis of diabetes mellitus, dyslipidemia, hypertension, and/or smoking based on information derived from administrative databases, and not known to have atherosclerotic disease, were enrolled. Before the scheduled appointment, potential study participants completed a telephone interview to ascertain their medical history. The ankle-brachial index (ABI) of eligible patients was measured at the time of the scheduled primary care office visit. Peripheral arterial disease was diagnosed if 1 or both legs had an ABI of  0.90. Also assessed was the time spent in performing ABI testing in a convenience sample of the study participants. ABI testing was performed on 717 patients. Among 359 study subjects aged  70 years, 45 (12.5%) were diagnosed with peripheral arterial disease. Nine (2.5%) of 358 subjects aged 50-69 years were diagnosed with peripheral arterial disease. The average total time (n=52) for ABI testing was 13.7 (SD: ±3.3) minutes. Patients aged 70 years required more time for ABI testing compared to those aged 50-69 (mean: 15.0 vs 13.0 minutes, p=0.04). Unrecognized asymptomatic peripheral arterial disease can be commonly detected among patients in the primary care setting who are not already known to have atherosclerotic disease. The yield from screening is substantially greater among unselected older patients compared with younger patients specifically identified as having risk factors for PAD. These findings should help inform the development and implementation of new initiatives to enhance the early detection of peripheral arterial disease among asymptomatic patients in the primary care setting.
References
- Fowkes FG, Housley E, Cawood EH, et al: Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20:384-392, 1991.[Abstract/Free Full Text]
- Criqui MH, Fronek A, Barrett-Connor E, et al: The prevalence of peripheral arterial disease in a defined population. Circulation 71:510-515, 1985.[Abstract/Free Full Text]
- Collins TC, Petersen NJ, Suarez-Almazor M, et al: The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med 163: 1469-1474, 2003.[Abstract/Free Full Text]
- McDermott MM, Kerwin DR, Liu K, et al: Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med 16:384-390, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hirsch AT, Criqui MH, Treat-Jacobson D, et al: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286:1317-1324, 2001.[Abstract/Free Full Text]
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421, 2002.[Free Full Text]
- Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560-2572, 2003.[Abstract/Free Full Text]
- Weitz JI, Byrne J, Clagett GP, et al: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation 94: 3026-3049, 1996.[Free Full Text]
- Antithrombotic Trialists’ Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71-86, 2002.[Abstract/Free Full Text]
- Orchard TJ, Strandness DE Jr: Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992, New Orleans, Louisiana. Circulation 88:819-828, 1993.[Free Full Text]
- American Diabetes Association: Peripheral arterial disease in people with diabetes. Diabetes Care 26: 3333-3341, 2003.[Free Full Text]
- Hirsch AT, Gloviczki P, Drooz A, et al: Mandate for creation of a national peripheral arterial disease public awareness program: An opportunity to improve cardiovascular health. J Vasc Surg 39:474-481, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jimbo M: Diagnosis and treatment of peripheral arterial disease. JAMA 287:314-315, 2002.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Criqui MH, Denenberg JO, Langer RD, et al: The epidemiology of peripheral arterial disease: Importance of identifying the population at risk. Vasc Med 2:221-226, 1997.[Medline]
[Order article via Infotrieve]
- Kannel WB, McGee DL: Update on some epidemiologic features of intermittent claudication: The Framingham Study. J Am Geriatr Soc 33:13-18, 1985.[Web of Science][Medline]
[Order article via Infotrieve]
- Morrison AS: Public health value of using epidemiologic information to identify high-risk groups for bladder cancer screening. Semin Oncol 6:184-188, 1979.[Web of Science][Medline]
[Order article via Infotrieve]
- Hoffman CR, Rice D, Sung H: Persons with chronic conditions. Their prevalence and costs. JAMA 276: 1473-1479, 1996.[Abstract/Free Full Text]
- McGlynn EA, Asch SM, Adams J, et al: The quality of health care delivered to adults in the United States. N Engl J Med 348:2635-2645, 2003.[Abstract/Free Full Text]
- Mechanic D, McAlpine DD, Rosenthal M: Are patients’ office visits with physicians getting shorter? N Engl J Med 344:198-204, 2001.[Abstract/Free Full Text]
- Yarnall KS, Pollak KI, Ostbye T, et al: Primary care: Is there enough time for prevention? Am J Public Health 93:635-641, 2003.[Abstract/Free Full Text]
Angiology, Vol. 57, No. 2,
171-180 (2006)
DOI: 10.1177/000331970605700206
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
K. I. Paraskevas, T. T. Papas, P. Pavlidis, N. Bessias, and V. Andrikopoulos
The Importance of Conservative Measures in Peripheral Arterial Disease: An Update
Angiology,
October 1, 2008;
59(5):
529 - 533.
[PDF]
|
|
|
|
|
